Objectives: Synthetic oligonucleotides have shown promise in brain imaging.
| INTRODUC TI ON
A variety of diseases in the central nervous system (CNS), such as brain glioma, Parkinson disease and Huntington's disease, is often characterized by altered cell proliferation and dysregulation of certain biomolecules. [1] [2] [3] [4] Thus, imaging of brain cells with high spatial resolution is highly desirable. 5, 6 In recent decades, synthesized single-stranded short nucleic acids (oligonucleotides) have been intensively investigated as molecular probes [7] [8] [9] [10] [11] [12] [13] or signal generator/amplifier [14] [15] [16] for brain imaging, owing to their sequence-dependent specificity in binding target molecules/cells or generating signals in situ. 17 However, efficient delivery of synthesized oligonucleotides into live CNS remains a grand challenge, due to that the oligonucleotides (especially ssDNAs) can hardly be delivered by conventional viral vectors. Their poor structural stability, penetrability and cell uptake efficiency in the highly complex nervous system limit the use of direct local delivery.
One traditional approach for improving the oligonucleotide delivery efficiency is to use carriers like cationic lipids, polymers and nanoparticles, which help the anionic oligonucleotides overcome the Coulomb repulsion from the negatively charged cell membrane, thus favour the cell entry 10, [18] [19] [20] [21] ; another approach is to covalently functionalize the oligonucleotides with chemical groups and molecules (eg, thiophosphorylation, 2′-O-methylation, 2′-O-methoxyethylation, 2′-fluoro substitution, locked nucleic acid modification and peptide nucleic acid modification). 22, 23 These strategies can strengthen the structural stability of the oligonucleotides and improve their efficiency to penetrate the physiological barriers and enter the target cells. However, these strategies still suffer from either low efficiency or inconvenience, which usually require high dose and repetitive administration of synthetic materials/chemicals. 27, 28 Here in this study, we aim to develop a facile yet efficient strat- 
| MATERIAL S AND ME THODS

| Materials
Citrate and trisodium citrate dihydrate were obtained from Sinopharm Chemical Reagent Co., Ltd. The sodium citrate buffer (100 mmol/L, pH = 3) was prepared by mixing 100 mmol/L citrate acid and sodium citrate. The 28-nt Cy3-labelled ODN (5′-3′ sequence:
TTGCACATGCCGGAGCCGTTGTCGACGA) was synthesized and purified by Sangon Biotech (China). All chemicals and reagents were of analytical grade.
| Animals
Adult male C57BL/6 mice (purchased from Shanghai Biomodel Organism Science & Technology Development Co., Ltd.) were used in this study. The animals were housed in cages under standard laboratory conditions (12:12 hour light-dark cycle, 20 ± 1°C, food and water ad libitum). All experimental procedures were performed according to institutional guidelines.
| Stereotaxic injection
The ODN ( 
| Perfusion and tissue preparation
Six hours after injection, the animals were anaesthetized with an overdose of 1% sodium pentobarbital solution and intracardially perfused with 4% paraformaldehyde in phosphate-buffered saline (PBS, pH = 7.4). Brains were dissected and post-fixed in the same fixative for 2 hours and immersed in 30% sucrose solution at room temperature overnight. Mouse brains were cut on a freezing microtome (LEICA CM3050 S) in the coronal plane (50 µm thickness).
All sections were collected on microslides, washed three times for 5 minute each in PBS and mounted with a mounting agent with DAPI (4′,6-diamidino-2-phenylindole, dihydrochloride, 1 µg/mL) and 50%
(v/v) glycerol in PBS.
| Imaging and data analysis
Images of brain sections were acquired using a Nikon AR1 confocal microscope. Representative sections from three cases of each condition covering the centre of injection sites were imaged. Delivery area and cell counts were estimated using ImageJ software. Briefly, the area with fluorescence above the threshold (mean background)
was calculated, and all cells within the delivery area were counted with ImageJ. Data were analysed using one-way ANOVA followed by Turkey's post hoc test. P < 0.05 was considered statistically significant.
| RE SULTS
We first test whether the citrate acid can promote the cell entry of ODNs in the mouse brain. We mixed a Cy3-labelled 28-nt ODN with citrate acid solution (100 mmol/L, pH = 3) and carried out a stereotactic injection of the mixture (1 µL each injection) into the brain parenchyma of live mice (Schematic shown in Figure 1A ). Six hours after the injection, we sacrificed the mice and prepared 50 µm thick brain slices for confocal microscopic imaging. As shown in Figure 1B Figure 1C ). Meanwhile, using hydrochloric acid (HCl, also pH = 3) instead of citrate acid also led to few fluorescent cells (<10 on average), and the fluorescent ODNs were mostly distributed in the extracellular space (ECS; Figure 1D ,E). We also found that the citrate-assisted injection led to a ~15-fold larger fluorescence diffusion area compared with which used HCl ( Figure 1E ), which also reflects the improved delivery efficiency resulted from the citrate.
Based on the above results, we reason that an acidic local environment around the injection site favours the diffusion and cell entry of the ODNs. Although the HCl solution is also acidic, it lacks the buffering capacity to maintain the acidity of the local environment.
In contrary, citrate is an excellent pH buffer, which might contribute to the difference in delivery efficiency between using citrate and using HCl.
Next, we studied the effect of buffering capacity on delivery efficiency. Given that the buffering capacity is largely determined by the buffer concentration, we prepared citrate buffer solutions with identical pH (pH = 3) but different citrate concentrations (10, Within the range we tested, pH = 3 was the optimal pH value for the delivery of ODNs. It is known that DNA molecule and cell membrane are both negatively charged under the neutral condition, leading to Coulomb repulsion that hampers the cell entry of DNA. We reason that the acidic environment can protonate the DNA bases (with an estimated isoelectric point of about 4~5 29 ) and some membrane proteins (with isoelectric points <7), 30 thus reduces the overall Coulomb repulsion. 31 Moreover, compared with buffers of higher pH, the buffer of pH 3 can also provide a higher buffer capacity to maintain the acidic environment. These factors may together contribute to the improved ODN delivery. However, according to published literature, reducing the pH further is unlikely to be feasible considering DNA depurination and cleavage reactions at extremely low pH.
32,33
The brain is highly heterogeneous in structure and function ( Figure 4A ). To demonstrate the generality of this delivery strategy, we performed the injections towards different brain regions.
Here, the Cy3-labelled ODN mixed with citrate buffer (100 mmol/L, pH = 3) was injected into four different brain regions, including striatum, cortex, hippocampus and midbrain, respectively. As results 
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